mRNA Vaccines and Therapeutics Market Size, Share, Growth, and Industry Analysis, By Type (COVID Vaccines, Infectious Disease Vaccines, Cancer Vaccines, Autoimmune Diseases, Others), By Application (Hospitals & Clinics, Research Organization, Others), Regional Insights and Forecast to 2035

Table of Content

1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global mRNA Vaccines and Therapeutics Market Size
1.3 Market Segmentation
1.4 Regulatory Environment

2 Industry Chain Analysis
2.1 Industry Chain Analysis
2.2 mRNA Vaccines and Therapeutics Raw Materials Analysis
2.2.1 Key Raw Materials Introduction
2.2.2 Key Suppliers of Raw Materials
2.3 mRNA Vaccines and Therapeutics Business Mode and Production Process
2.3.1 mRNA Vaccines and Therapeutics Business Mode Analysis
2.3.2 Production Process Analysis
2.4 mRNA Vaccines and Therapeutics Cost Structure Analysis
2.4.1 Manufacturing Cost Structure of mRNA Vaccines and Therapeutics
2.4.2 Raw Material Cost of mRNA Vaccines and Therapeutics
2.4.3 Labor Cost of mRNA Vaccines and Therapeutics
2.5 Market Channel Analysis
2.6 Major Downstream Customers Analysis
2.7 Alternative Product Analysis

3 Market Dynamics
3.1 Market Drivers
3.2 Market Constraints and Challenges
3.3 Emerging Market Trends
3.4 PESTEL Analysis
3.5 Consumer Insights Analysis
3.6 Impact of Russia and Ukraine War

4 Market Competitive Landscape
4.1 Global mRNA Vaccines and Therapeutics Revenue and Market Share by Manufacturer (2021-2026)
4.2 Global mRNA Vaccines and Therapeutics Sales Volume and Market Share by Manufacturer (2021-2026)
4.3 Global mRNA Vaccines and Therapeutics Price by Manufacturer (2021-2026)
4.4 mRNA Vaccines and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
4.5 Global Key Manufacturers of mRNA Vaccines and Therapeutics, Manufacturing Base Distribution and Headquarters
4.6 Global Key Manufacturers of mRNA Vaccines and Therapeutics, Product Offered and Application
4.7 mRNA Vaccines and Therapeutics Market Competitive Situation and Trends
4.7.1 mRNA Vaccines and Therapeutics Market Concentration Rate
4.7.2 Global Top 3 and Top 6 mRNA Vaccines and Therapeutics Players Market Share by Revenue
4.8 Industry News
4.8.1 Key Product Launch News
4.8.2 Mergers & Acquisitions, Expansion Plans

5 Global mRNA Vaccines and Therapeutics Market Historical Development by Geographic Region (2021-2026)
5.1 Global mRNA Vaccines and Therapeutics Market Historical Sales Volume by Geographic Region (2021-2026)
5.2 Global mRNA Vaccines and Therapeutics Market Historical Revenue by Geographic Region (2021-2026)
5.3 North America mRNA Vaccines and Therapeutics Market Status by Country (2021-2026)
5.3.1 North America mRNA Vaccines and Therapeutics Sales Volume by Country (2021-2026)
5.3.2 North America mRNA Vaccines and Therapeutics Revenue by Country (2021-2026)
5.3.3 United States mRNA Vaccines and Therapeutics Sales Volume, Revenue and Growth (2021-2026)
5.3.4 Canada mRNA Vaccines and Therapeutics Sales Volume, Revenue and Growth (2021-2026)
5.4 Europe mRNA Vaccines and Therapeutics Market Status by Country (2021-2026)
5.4.1 Europe mRNA Vaccines and Therapeutics Sales Volume by Country (2021-2026)
5.4.2 Europe mRNA Vaccines and Therapeutics Revenue by Country (2021-2026)
5.4.3 Germany mRNA Vaccines and Therapeutics Sales Volume, Revenue and Growth (2021-2026)
5.4.4 France mRNA Vaccines and Therapeutics Sales Volume, Revenue and Growth (2021-2026)
5.4.5 United Kingdom mRNA Vaccines and Therapeutics Sales Volume, Revenue and Growth (2021-2026)
5.4.6 Spain mRNA Vaccines and Therapeutics Sales Volume, Revenue and Growth (2021-2026)
5.4.7 Russia mRNA Vaccines and Therapeutics Sales Volume, Revenue and Growth (2021-2026)
5.4.8 Poland mRNA Vaccines and Therapeutics Sales Volume, Revenue and Growth (2021-2026)
5.5 Asia Pacific mRNA Vaccines and Therapeutics Market Status by Country (2021-2026)
5.5.1 Asia Pacific mRNA Vaccines and Therapeutics Sales Volume by Country (2021-2026)
5.5.2 Asia Pacific mRNA Vaccines and Therapeutics Revenue by Country (2021-2026)
5.5.3 China mRNA Vaccines and Therapeutics Sales Volume, Revenue and Growth (2021-2026)
5.5.4 Japan mRNA Vaccines and Therapeutics Sales Volume, Revenue and Growth (2021-2026)
5.5.5 South Korea mRNA Vaccines and Therapeutics Sales Volume, Revenue and Growth (2021-2026)
5.5.6 Southeast Asia mRNA Vaccines and Therapeutics Sales Volume, Revenue and Growth (2021-2026)
5.5.7 India mRNA Vaccines and Therapeutics Sales Volume, Revenue and Growth (2021-2026)
5.5.8 Australia mRNA Vaccines and Therapeutics Sales Volume, Revenue and Growth (2021-2026)
5.6 Latin America mRNA Vaccines and Therapeutics Market Status by Country (2021-2026)
5.6.1 Latin America mRNA Vaccines and Therapeutics Sales Volume by Country (2021-2026)
5.6.2 Latin America mRNA Vaccines and Therapeutics Revenue by Country (2021-2026)
5.6.3 Mexico mRNA Vaccines and Therapeutics Sales Volume, Revenue and Growth (2021-2026)
5.6.4 Brazil mRNA Vaccines and Therapeutics Sales Volume, Revenue and Growth (2021-2026)
5.7 Middle East and Africa mRNA Vaccines and Therapeutics Market Status by Country (2021-2026)
5.7.1 Middle East and Africa mRNA Vaccines and Therapeutics Sales Volume by Country (2021-2026)
5.7.2 Middle East and Africa mRNA Vaccines and Therapeutics Revenue by Country (2021-2026)
5.7.3 GCC mRNA Vaccines and Therapeutics Sales Volume, Revenue and Growth (2021-2026)
5.7.4 South Africa mRNA Vaccines and Therapeutics Sales Volume, Revenue and Growth (2021-2026)

6 Global mRNA Vaccines and Therapeutics Market Historical Development by Product Type (2021-2026)
6.1 mRNA Vaccines and Therapeutics Definition by Type
6.2 Global mRNA Vaccines and Therapeutics Historical Sales Volume by Product Type (2021-2026)
6.3 Global mRNA Vaccines and Therapeutics Historical Revenue by Product Type (2021-2026)
6.4 Global mRNA Vaccines and Therapeutics Historical Price by Product Type (2021-2026)
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)
6.5.1 Global mRNA Vaccines and Therapeutics Historical Sales Volume, Revenue and Growth Rate of COVID Vaccines (2021-2026)
6.5.2 Global mRNA Vaccines and Therapeutics Historical Sales Volume, Revenue and Growth Rate of Infectious Disease Vaccines (2021-2026)
6.5.3 Global mRNA Vaccines and Therapeutics Historical Sales Volume, Revenue and Growth Rate of Cancer Vaccines (2021-2026)
6.5.4 Global mRNA Vaccines and Therapeutics Historical Sales Volume, Revenue and Growth Rate of Autoimmune Diseases (2021-2026)
6.5.5 Global mRNA Vaccines and Therapeutics Historical Sales Volume, Revenue and Growth Rate of Others (2021-2026)

7 Global mRNA Vaccines and Therapeutics Market Historical Development by End User (2021-2026)
7.1 Downstream Market Overview
7.2 Global mRNA Vaccines and Therapeutics Historical Sales Volume by End User (2021-2026)
7.3 Global mRNA Vaccines and Therapeutics Historical Revenue by End User (2021-2026)
7.4 Global mRNA Vaccines and Therapeutics Historical Price by End User (2021-2026)
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)
7.5.1 Global mRNA Vaccines and Therapeutics Historical Sales Volume, Revenue and Growth Rate of Hospitals & Clinics (2021-2026)
7.5.2 Global mRNA Vaccines and Therapeutics Historical Sales Volume, Revenue and Growth Rate of Research Organization (2021-2026)
7.5.3 Global mRNA Vaccines and Therapeutics Historical Sales Volume, Revenue and Growth Rate of Others (2021-2026)

8 Leading Companies Profiles
8.1 Intellia Therapeutics
8.1.1 Intellia Therapeutics Corporation Information
8.1.2 Intellia Therapeutics - mRNA Vaccines and Therapeutics Product Portfolio and Specification
8.1.3 Intellia Therapeutics Performance Analysis (2021-2026)
8.1.4 Intellia Therapeutics Business and Markets Served
8.1.5 Intellia Therapeutics Recent Developments
8.2 Moderna
8.2.1 Moderna Corporation Information
8.2.2 Moderna - mRNA Vaccines and Therapeutics Product Portfolio and Specification
8.2.3 Moderna Performance Analysis (2021-2026)
8.2.4 Moderna Business and Markets Served
8.2.5 Moderna Recent Developments
8.3 Sangamo Therapeutics
8.3.1 Sangamo Therapeutics Corporation Information
8.3.2 Sangamo Therapeutics - mRNA Vaccines and Therapeutics Product Portfolio and Specification
8.3.3 Sangamo Therapeutics Performance Analysis (2021-2026)
8.3.4 Sangamo Therapeutics Business and Markets Served
8.3.5 Sangamo Therapeutics Recent Developments
8.4 AstraZeneca Plc
8.4.1 AstraZeneca Plc Corporation Information
8.4.2 AstraZeneca Plc - mRNA Vaccines and Therapeutics Product Portfolio and Specification
8.4.3 AstraZeneca Plc Performance Analysis (2021-2026)
8.4.4 AstraZeneca Plc Business and Markets Served
8.4.5 AstraZeneca Plc Recent Developments
8.5 Bayer Group
8.5.1 Bayer Group Corporation Information
8.5.2 Bayer Group - mRNA Vaccines and Therapeutics Product Portfolio and Specification
8.5.3 Bayer Group Performance Analysis (2021-2026)
8.5.4 Bayer Group Business and Markets Served
8.5.5 Bayer Group Recent Developments
8.6 Boehringer Ingelheim
8.6.1 Boehringer Ingelheim Corporation Information
8.6.2 Boehringer Ingelheim - mRNA Vaccines and Therapeutics Product Portfolio and Specification
8.6.3 Boehringer Ingelheim Performance Analysis (2021-2026)
8.6.4 Boehringer Ingelheim Business and Markets Served
8.6.5 Boehringer Ingelheim Recent Developments
8.7 BioNtech
8.7.1 BioNtech Corporation Information
8.7.2 BioNtech - mRNA Vaccines and Therapeutics Product Portfolio and Specification
8.7.3 BioNtech Performance Analysis (2021-2026)
8.7.4 BioNtech Business and Markets Served
8.7.5 BioNtech Recent Developments
8.8 Pfizer
8.8.1 Pfizer Corporation Information
8.8.2 Pfizer - mRNA Vaccines and Therapeutics Product Portfolio and Specification
8.8.3 Pfizer Performance Analysis (2021-2026)
8.8.4 Pfizer Business and Markets Served
8.8.5 Pfizer Recent Developments
8.9 GlaxoSmithKline
8.9.1 GlaxoSmithKline Corporation Information
8.9.2 GlaxoSmithKline - mRNA Vaccines and Therapeutics Product Portfolio and Specification
8.9.3 GlaxoSmithKline Performance Analysis (2021-2026)
8.9.4 GlaxoSmithKline Business and Markets Served
8.9.5 GlaxoSmithKline Recent Developments
8.10 Crispr Therapeutics
8.10.1 Crispr Therapeutics Corporation Information
8.10.2 Crispr Therapeutics - mRNA Vaccines and Therapeutics Product Portfolio and Specification
8.10.3 Crispr Therapeutics Performance Analysis (2021-2026)
8.10.4 Crispr Therapeutics Business and Markets Served
8.10.5 Crispr Therapeutics Recent Developments

9 Global mRNA Vaccines and Therapeutics Market Forecast by Product Type and End User (2026-2034)
9.1 Global mRNA Vaccines and Therapeutics Market Forecast by Product Type (2026-2034)
9.1.1 Global mRNA Vaccines and Therapeutics Sales Volume, Revenue Forecast and Growth Rate of COVID Vaccines (2026-2034)
9.1.2 Global mRNA Vaccines and Therapeutics Sales Volume, Revenue Forecast and Growth Rate of Infectious Disease Vaccines (2026-2034)
9.1.3 Global mRNA Vaccines and Therapeutics Sales Volume, Revenue Forecast and Growth Rate of Cancer Vaccines (2026-2034)
9.1.4 Global mRNA Vaccines and Therapeutics Sales Volume, Revenue Forecast and Growth Rate of Autoimmune Diseases (2026-2034)
9.1.5 Global mRNA Vaccines and Therapeutics Sales Volume, Revenue Forecast and Growth Rate of Others (2026-2034)
9.2 Global mRNA Vaccines and Therapeutics Market Forecast by End User (2026-2034)
9.2.1 Global mRNA Vaccines and Therapeutics Sales Volume, Revenue Forecast and Growth Rate of Hospitals & Clinics (2026-2034)
9.2.2 Global mRNA Vaccines and Therapeutics Sales Volume, Revenue Forecast and Growth Rate of Research Organization (2026-2034)
9.2.3 Global mRNA Vaccines and Therapeutics Sales Volume, Revenue Forecast and Growth Rate of Others (2026-2034)

10 Global mRNA Vaccines and Therapeutics Market Forecast by Geographic Region (2026-2034)
10.1 Global mRNA Vaccines and Therapeutics Sales Volume and Revenue Forecast by Geographic Region (2026-2034)
10.2 North America mRNA Vaccines and Therapeutics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.1 United States mRNA Vaccines and Therapeutics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.2 Canada mRNA Vaccines and Therapeutics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3 Europe mRNA Vaccines and Therapeutics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.1 Germany mRNA Vaccines and Therapeutics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.2 France mRNA Vaccines and Therapeutics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.3 United Kingdom mRNA Vaccines and Therapeutics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.4 Spain mRNA Vaccines and Therapeutics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.5 Russia mRNA Vaccines and Therapeutics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.6 Poland mRNA Vaccines and Therapeutics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4 Asia Pacific mRNA Vaccines and Therapeutics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.1 China mRNA Vaccines and Therapeutics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.2 Japan mRNA Vaccines and Therapeutics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.3 South Korea mRNA Vaccines and Therapeutics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.4 Southeast Asia mRNA Vaccines and Therapeutics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.5 India mRNA Vaccines and Therapeutics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.6 Australia mRNA Vaccines and Therapeutics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5 Latin America mRNA Vaccines and Therapeutics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.1 Mexico mRNA Vaccines and Therapeutics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.2 Brazil mRNA Vaccines and Therapeutics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6 Middle East and Africa mRNA Vaccines and Therapeutics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.1 GCC mRNA Vaccines and Therapeutics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.2 South Africa mRNA Vaccines and Therapeutics Sales Volume, Revenue Forecast and Growth (2026-2034)

11 Appendix
11.1 Methodology
11.2 Research Data Source
11.2.1 Secondary Data
11.2.2 Primary Data
11.2.3 Market Size Estimation
11.2.4 Legal Disclaimer